High Costs, Low Margins, and Regulatory Hurdles Hinder Pharma’s Adoption of Advanced Manufacturing Technologies

Benchmark Banner Ad

 

The ongoing drug shortage crisis in the U.S. underscores a critical need for innovation in pharmaceutical manufacturing. As manufacturing issues, outdated technologies, and geopolitical risks contribute to shortages that impact patient care and elevate healthcare costs, the introduction of Advanced Manufacturing Technologies (AMTs) offers a beacon of hope. AMT technologies promise to enhance quality control and reduce production downtime, yet their adoption in generic drug production remains low despite obvious benefits.

Why is the pharmaceutical industry slow to adopt technologies that could revolutionize drug availability and cost?

Mike Tracy, a C-Level Healthcare Operations Strategist, dives into the complexities of integrating Advanced Manufacturing Technologies in drug production. Mike points out that while AMTs can drastically reduce bottlenecks in drug production, the significant initial investment and stringent regulatory landscape pose substantial hurdles.

“Every AMT has a high startup cost and generic drugs have very razor-thin margins to begin with. We’re not talking about a new drug that’s not already out in the market where you’re going to have a high margin and it makes sense to invest millions,” Tracy explains.

Article written by Sonia Gossai

Follow us on social media for the latest updates in B2B!

Image

Latest

medical worker shortage
Experiential Learning: A Cure for the Medical Worker Shortage with Jason Aubrey of Skilltrade
January 26, 2026

Healthcare systems across the U.S. are facing a persistent and worsening medical worker shortage, particularly in allied health roles that keep hospitals, clinics, and surgery centers running. Rural access gaps, rising tuition costs, and skepticism about the ROI of traditional degrees are colliding with urgent employer demand. At the same time, momentum is building…

Read More
Broadband
2025 Broadband Year in Review, Part 2
January 23, 2026

In this episode of Wavelengths, the Amphenol Broadband Solutions podcast, host Daniel Litwin continues his conversation with Alex Rozek, Founder and CEO of Mac Mountain, to examine how technology shifts, capital discipline, and changing consumer expectations reshaped broadband in 2025, and what those changes lock in for the future. As the broadband industry closes…

Read More
branding
Bonfire Branding: How Solo Stove Sparked a Customer Movement with Liz Vanzura (Episode One)
January 22, 2026

When pandemic restrictions shut down restaurants, paused travel, and compressed social lives, connection didn’t disappear; it moved closer to home. Backyards quietly emerged as important gathering spaces, offering a simple way to be together without screens, schedules, or spectacle. What began as a workaround evolved into a familiar rhythm of gathering. In that shift,…

Read More
customer movement
Bonfire Branding: How Solo Stove Sparked a Customer Movement with Liz Vanzura (Episode Three)
January 22, 2026

As audiences tune out polished ads and lean into trust, brands are being forced to rethink how they show up for the customer. Research consistently shows that consumers rate peer-created content as more credible than traditional brand messaging, and algorithmic discovery is increasingly rewarding authenticity over polish. With AI reshaping how people search and…

Read More